Explore all the latest information in acute myeloid leukemia, arranged by key congresses and meetings. Listed below are recently updated congresses and meetings.
How can MRD testing be put to best use in AML?
During the 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the AML Hub spoke to Ali Bazarbachi, American...
How can CRISPR be used for adoptive T-cell therapy in AML?
During the 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the AML Hub spoke to Eliana Ruggiero,...
Lower overall survival in ELN favorable-risk AML with DNA-MR mutations
The 2017 European LeukemiaNet (ELN) recommendations separate patients with acute myeloid leukemia (AML) into three risk groups...
How cytogenetic risk impacts the outcome of allogeneic stem cell transplantation
Cytogenetic profile is a predictor of outcome in patients with acute myeloid leukemia (AML). It also helps with the...
Initiation of the first-in-human trial of allogeneic NKG2D-directed CAR NK-cell therapy to treat R/R AML or high-risk R/R MDS
Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) are...
Preliminary data from novel DLI strategies show a lower risk of GvHD
With the increased use of haploidentical allogeneic hematopoietic stem cell transplantation (allo-HSCT), treatment of patients...
How can we improve efficacy of CAR T-cell therapy in AML?
During the 3rd European CAR T-cell Meeting, the AML Hub spoke to Naval Daver, MD Anderson Cancer Center, Houston, US. We asked, How can we...
CAR-T 2020 | Cytopenia in CART — the prolonged threat of infection
Cytopenia has been reported following lymphodepletion and CAR T-cell infusion with axicabtagene ciloleucel (axi-cel) and...
American Association for Cancer Research
American Society of Clinical Oncology
American Society of Hematology
EHA–EBMT European CAR T-Cell Meetings
European Hematology Association
European School of Haematology
European Society for Blood and Marrow Transplantation
International Academy for Clinical Hematology
International Symposium on Acute Leukemias
National Cancer Research Institute
NCRI AML Academy 2019
NCRI AML Academy 2020
National Comprehensive Cancer Network
Society of Hematologic Oncology
Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR